OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 134 citing articles:

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 133

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
Guang Lei, Li Zhuang, Boyi Gan
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 513-534
Open Access | Times Cited: 98

The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 57

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 38

crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 20

Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics
Gang Che, Jie Yin, Wankun Wang, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101080-101080
Closed Access | Times Cited: 16

The crosstalk between exosomal miRNA and ferroptosis: A narrative review
Zahra Nashtahosseini, Masoumeh Nejatollahi, Ahmad Fazilat, et al.
Biology of the Cell (2025) Vol. 117, Iss. 1
Closed Access | Times Cited: 3

Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1

Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance
Zehua Zhao, Tianming Li, Liping Sun, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115425-115425
Open Access | Times Cited: 26

Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13

Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy
Yi-Chi Yang, Qian Jiang, Ke-Ping Yang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12

Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Yuting Wu, Xi Pu, Xu Wang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12

Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers
Yuan Li, Silei Sui, Ajay Goel
Seminars in Cancer Biology (2024) Vol. 99, pp. 5-23
Closed Access | Times Cited: 12

Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer
Yuchao Zhu, Shuai Fang, Bolin Fan, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1683-1700
Open Access | Times Cited: 11

Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look
Zahra Abbasi‐Malati, Seyed Ghader Azizi, Soheil Zamen Milani, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8

CD63+ cancer-associated fibroblasts confer CDK4/6 inhibitor resistance to breast cancer cells by exosomal miR-20
Jiahui Sun, Ruoxin Du, Xiaoju Li, et al.
Cancer Letters (2024) Vol. 588, pp. 216747-216747
Open Access | Times Cited: 7

Biophysical and biochemical aspects of immune cell–tumor microenvironment interactions
Shoham Benmelech, Thien Le, M. McKay, et al.
APL Bioengineering (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 7

Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 7

Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6

A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3406-3406
Open Access | Times Cited: 6

Advances in exosomes utilization for clinical applications in cancer
Inês A. Batista, José Carlos Machado, Sónia A. Melo
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 947-968
Closed Access | Times Cited: 6

Chemoresistance and the tumor microenvironment: the critical role of cell–cell communication
Bartosz Wilczyński, Alicja Dąbrowska, Julita Kulbacka, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Unveiling the role of ferroptosis-associated exosomal non-coding RNAs in cancer pathogenesis
Yiping Zhang, Jun Xie
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116235-116235
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top